The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 02, 2022

Filed:

Oct. 13, 2016
Applicant:

Max-delbrueck-centrum Fuer Molekulare Medizin IN Der Helmholtz-gemeinschaft, Berlin, DE;

Inventors:

Thomas Blankenstein, Berlin, DE;

Gerald Willimsky, Berlin, DE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61P 31/20 (2006.01); C07K 14/005 (2006.01); C07K 14/725 (2006.01); C12N 5/0783 (2010.01); C07K 16/08 (2006.01); A61K 39/12 (2006.01); A61K 39/00 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/7051 (2013.01); A61K 39/12 (2013.01); A61P 31/20 (2018.01); C07K 14/005 (2013.01); C07K 16/08 (2013.01); C07K 16/084 (2013.01); C12N 5/0636 (2013.01); A61K 48/00 (2013.01); A61K 2039/5156 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/585 (2013.01); C07K 2317/565 (2013.01); C07K 2318/00 (2013.01); C12N 2510/00 (2013.01); C12N 2710/20034 (2013.01);
Abstract

The present invention pertains to novel high avidity antigen recognizing constructs against Human Papilloma Virus antigens. The invention provides novel T cell receptor (TCR) based molecules which are selective and specific for HPV 16/18 proteins E5, E6 and E7. The TCR of the invention, and HPV antigen-binding fragments derived therefrom, are of use for the diagnosis, treatment and prevention of HPV infection, as well as for the diagnosis, treatment and prevention of HPV infection mediated secondary diseases as HPV infection caused cancers, such as cervical, nasopharyngeal or head and neck cancer. Further provided are nucleic acids encoding the proteins of the invention, and recombinant cells expressing the same.


Find Patent Forward Citations

Loading…